Proshares Trust (ZBIO) Equity Ratio (2023 - 2025)
Historic Equity Ratio for Zenas BioPharma (ZBIO) over the last 3 years, with Q3 2025 value amounting to 0.61.
- Zenas BioPharma's Equity Ratio fell 3153.43% to 0.61 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.61, marking a year-over-year decrease of 3153.43%. This contributed to the annual value of 0.84 for FY2024, which is 12551.01% up from last year.
- Latest data reveals that Zenas BioPharma reported Equity Ratio of 0.61 as of Q3 2025, which was down 3153.43% from 0.82 recorded in Q2 2025.
- In the past 5 years, Zenas BioPharma's Equity Ratio registered a high of 0.89 during Q3 2024, and its lowest value of 3.31 during Q4 2023.
- In the last 3 years, Zenas BioPharma's Equity Ratio had a median value of 0.83 in 2025 and averaged 0.12.
- Per our database at Business Quant, Zenas BioPharma's Equity Ratio skyrocketed by 12551.01% in 2024 and then plummeted by 3153.43% in 2025.
- Zenas BioPharma's Equity Ratio (Quarter) stood at 3.31 in 2023, then skyrocketed by 125.51% to 0.84 in 2024, then dropped by 27.77% to 0.61 in 2025.
- Its last three reported values are 0.61 in Q3 2025, 0.82 for Q2 2025, and 0.85 during Q1 2025.